Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| − | <br >Note: The last meeting of this group was held on | + | <br >Note: The last meeting of this group was held on January 23, 2020; notes are posted after they are approved by the MRE BC during the following t-con |
*[[Media:2019_04-01_QIBA_MRE_BC_Call_Summary-FINAL.pdf|April 1, 2019]] | *[[Media:2019_04-01_QIBA_MRE_BC_Call_Summary-FINAL.pdf|April 1, 2019]] | ||
Revision as of 21:12, 23 January 2020
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries:
Note: The last meeting of this group was held on January 23, 2020; notes are posted after they are approved by the MRE BC during the following t-con
MRE Profile Development
- MR Elastography of the Liver 2018-05-02
- MRE Profile, Draft: July 28, 2017
- MRE Profile, Initial Draft: July 6, 2017